SCHEMBL27165476

SCHEMBL27165476

[N-]=[N+]=NCC(=O)N1CCN(C(=O)CN=[N+]=[N-])CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ USP2 O75604 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ GAA P10253 2/20 0.35
▸ JAK2 O60674 2/20 0.35
▸ JAK1 P23458 2/20 0.35
▸ UCHL1 P09936 2/20 0.33
▸ MAPK14 Q16539 1/20 0.33
▸ SIGMAR1 Q99720 1/20 0.33
▸ PARK7 Q99497 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17848825 0.92 MEN1 (0.33) ALDH1A1HSD17B10KDM4EMEN1USP2
SCHEMBL13655626 0.91 ATM (0.45) ALDH1A1MEN1HPGDKMT2ATDP1
SCHEMBL18803167 0.90 GAA (0.42) KMT2ATDP1GAAJAK2JAK1
SCHEMBL28395559 0.90 ATM (0.43) ALDH1A1HSD17B10MEN1LMNAHPGD
SCHEMBL13655637 0.86 L3MBTL1 (0.48) ALDH1A1HSD17B10KDM4EMEN1LMNA
SCHEMBL29969222 0.86 CA2 (0.39) KMT2AGAAJAK2JAK1UCHL1
SCHEMBL17848849 0.86 JAK2 (0.33) JAK2JAK1
SCHEMBL19121772 0.84 POLB (0.35) ALDH1A1HSD17B10KDM4EMEN1USP2
SCHEMBL15832603 0.83 ALDH1A1 (0.53) ALDH1A1KDM4EMEN1LMNAHPGD
SCHEMBL17820875 0.82 USP2 (0.45) MEN1USP2HPGDKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024046929-A1 A METHOD OF MODIFYING AN ORGANIC CYTOTOXIN FOR USE AS A PAYLOAD IN AN ANTIBODY-DRUG CONJUGATE AND MODIFIED ORGANIC CYTOTOXINS DERIVED THEREFROM SIMRIS BIOLOGICS GMBH (DE) 2024-03-07 — — WO disclosed
Send feedback